Benci, Joseph L.
Xu, Bihui
Qiu, Yu
Wu, Tony J.
Dada, Hannah
Twyman-Saint Victor, Christina
Cucolo, Lisa
Lee, David S.M.
Pauken, Kristen E.
Huang, Alexander C.
Gangadhar, Tara C.
Amaravadi, Ravi K.
Schuchter, Lynn M.
Feldman, Michael D.
Ishwaran, Hemant
Vonderheide, Robert H.
Maity, Amit
Wherry, E. John
Minn, Andy J.
Funding for this research was provided by:
Melanoma Research Alliance
Parker Institute for Cancer Immunotherapy
Robertson Foundation
Cancer Research Institute Irvington Fellowship
NIH (P50CA174523)
Basser Research Center for BRCA
NIH (R01CA163739)
NIH (R01CA158186, P30CA016520)
Abramson Cancer Center Translational Center of Excellence in Pancreatic Cancer
NIH (U19AI082630, R01AI105343, U01AI095608, P01AI112521)
Department of Defense Era of Hope Scholar (W81XWH-09-1-0339)
NIH
NCI (R01CA172651)
Merck
This article is maintained by: Elsevier
Article Title: Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Journal Title: Cell
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.cell.2016.11.022
Content Type: article
Copyright: © 2016 Elsevier Inc.